These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8261688)

  • 21. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Taurine as a regulator of fluid-electrolyte balance and arterial pressure].
    Ciechanowska B
    Ann Acad Med Stetin; 1997; 43():129-42. PubMed ID: 9471912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of vasopressin and of the atrial natriuretic peptide in blood pressure control.
    Szczepanska-Sadowska E
    Acta Physiol Scand Suppl; 1989; 583():79-87. PubMed ID: 2530757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.
    Dessì-Fulgheri P; Sarzani R; Rappelli A
    J Nephrol; 1998; 11(6):296-9. PubMed ID: 10048495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB; Pedersen EB
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic and natriuretic responses to ANF in the presence and absence of renal nerves in DOCA-salt hypertensive rats.
    Patel KP; Zeigler DW
    Clin Exp Hypertens; 1993 Mar; 15(2):257-70. PubMed ID: 8467316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):89-92. PubMed ID: 2954174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressure natriuresis in salt-sensitive and salt-resistant Sabra rats.
    Gross V; Lippoldt A; Yagil C; Yagil Y; Luft FC
    Hypertension; 1997 Jun; 29(6):1252-9. PubMed ID: 9180625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in urinary water and electrolyte excretion in sodium-loaded sheep in response to intravenous infusion of arginine vasopressin.
    Scott D; Morton JJ
    Q J Exp Physiol Cogn Med Sci; 1976 Jan; 61(1):57-70. PubMed ID: 1051692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of vasopressin in hypertension.
    Share L; Crofton JT
    Fed Proc; 1984 Jan; 43(1):103-6. PubMed ID: 6690329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
    Lee YJ; Shin SJ; Tan MS; Hsieh TJ; Tsai JH
    Am J Physiol; 1996 Oct; 271(4 Pt 2):F779-89. PubMed ID: 8898007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats.
    Rossoni LV; Pinto VD; Vassallo DV
    Braz J Med Biol Res; 2001 Aug; 34(8):1065-77. PubMed ID: 11471047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.